| 1991 |
The 160 kDa subunit of CPSF (CPSF1) directly contacts the AAUAAA hexamer signal in pre-mRNA, as demonstrated by UV crosslinking showing a 160 kDa polypeptide covalently linked to the RNA; chemical modification-exclusion experiments confirmed that CPF interacts directly with each base of the AAUAAA signal. |
UV crosslinking, gel mobility shift assays, chemical modification-exclusion experiments |
The EMBO journal |
High |
1756731
|
| 1995 |
The 160 kDa subunit of CPSF (CPSF1) was cloned and shown to: (1) bind preferentially to AAUAAA-containing RNAs by itself; (2) interact specifically with CstF-77 (the 77K subunit of cleavage factor CstF); and (3) bind poly(A) polymerase (PAP), providing a mechanistic basis for cooperative CPSF-CstF binding and for CPSF-stimulated poly(A) synthesis. Antibodies against recombinant CPSF1 inhibit polyadenylation in vitro, restored by purified CPSF. |
cDNA cloning, recombinant protein expression, RNA binding assays, co-immunoprecipitation/pulldown, in vitro polyadenylation inhibition with antibodies |
Genes & development |
High |
7590244
|
| 1997 |
CPSF specifically binds to the C-terminal domain (CTD) of RNA polymerase II, coupling mRNA 3'-end processing to transcription. CPSF and CstF co-purify with pol II in a high-molecular-mass complex, and CTD truncation inhibits efficient 3'-end processing and transcription termination. |
CTD affinity chromatography, co-purification, in vivo transcription and processing assays with CTD truncation mutants |
Nature |
High |
9002523
|
| 1997 |
CPSF is recruited to the transcription preinitiation complex by TFIID (via interaction with TBP-associated factors). After transcription initiation, CPSF dissociates from TFIID and associates with the elongating polymerase. Overexpression of recombinant TBP in HeLa cells reduces polyadenylation efficiency, demonstrating that TFIID-mediated CPSF recruitment is required for efficient 3'-end formation. |
Immunopurification of TFIID complex, co-purification/co-immunoprecipitation, in vivo overexpression assays in HeLa cells, reporter polyadenylation assays |
Nature |
High |
9311784
|
| 2000 |
CPSF (including the 160K/CPSF1 subunit), CstF, and symplekin can be isolated from cells as part of a large multiprotein complex, establishing that the mammalian polyadenylation machinery is pre-assembled into a holofactory complex. |
Immunoprecipitation, co-purification from cell extracts |
Molecular and cellular biology |
Medium |
10669729
|
| 2004 |
Human Fip1 (hFip1) is an integral subunit of the CPSF complex. hFip1 interacts with PAP and with CPSF160 (CPSF1) to form a ternary complex, and stimulates poly(A) polymerase activity in a U-rich element-dependent manner, identifying a cooperative interaction between hFip1 and CPSF1 in poly(A) site recognition and PAP recruitment. |
Protein purification, co-immunoprecipitation, in vitro polyadenylation assay, ternary complex reconstitution |
The EMBO journal |
High |
14749727
|
| 2011 |
In zebrafish, loss-of-function mutation in cpsf1 (grechetto mutant) causes defective polyadenylation of snrnp70 (a gene required for HSC development) and leads to apoptotic death of definitive hematopoietic stem cells (HSCs) in the caudal hematopoietic tissue, resulting in severe depletion of myeloid, erythroid, and lymphoid cells. Primitive hematopoiesis and HSC specification are normal, indicating a specific requirement for cpsf1 in HSC survival and differentiation. |
ENU mutagenesis screen in zebrafish, genetic mapping, loss-of-function mutation analysis, RT-PCR for polyadenylation of snrnp70, cell counting and apoptosis assays |
Blood |
High |
21330472
|
| 2012 |
CPSF1 regulates alternative splicing of IL7R exon 6 by binding to an intronic AAUAAA polyadenylation signal downstream of the exon 6 5' splice site. CPSF1 knockdown increases exon 6 inclusion; the effect is independent of productive cleavage/polyadenylation at this site, suggesting that CPSF1 binding to intronic pre-mRNA competes with spliceosome access to the 5' splice site. |
RNA affinity chromatography followed by mass spectrometry (to identify CPSF1), siRNA knockdown, minigene splicing reporter assays, mutation of AAUAAA signal |
RNA (New York, N.Y.) |
High |
23151878
|
| 2012 |
CPSF1 was identified as a bona fide mRNA-binding protein in human HeLa cells by UV crosslinking interactome capture, establishing it as an RNA-binding protein that directly contacts mRNA in a cellular context. |
UV crosslinking followed by oligo(dT) capture and mass spectrometry (interactome capture) |
Cell |
Medium |
22658674
|
| 2019 |
Heterozygous loss-of-function variants in CPSF1 are associated with early-onset high myopia. Knockdown of cpsf1 by morpholino in zebrafish produces small eyes and abnormal retinal ganglion cell (RGC) axon projection to the tectum; this phenotype is rescued by co-injection of cpsf1 mRNA, demonstrating a role for CPSF1 in RGC axon projection and eye development. |
Whole-exome sequencing, Sanger sequencing, morpholino knockdown in zebrafish, mRNA rescue experiments, RGC axon tracing |
Human molecular genetics |
High |
30689892
|
| 2020 |
CPSF1 overexpression in head and neck squamous cell carcinoma (HNSCC) promotes cell proliferation, colony formation, and inhibits apoptosis (validated in cell lines and xenografts). CPSF1 knockdown and overexpression experiments reveal that it broadly regulates alternative splicing events (ASEs) in cancer cells. |
TCGA data mining, CPSF1 knockdown and overexpression in cell lines, proliferation/colony/apoptosis assays, xenograft models, RNA-seq for ASE identification |
PloS one |
Medium |
32437477
|
| 2020 |
CPSF1 mediates retinal vascular function through suppression of MAPK/ERK pathway phosphorylation. In a streptozotocin-induced diabetic rat model and high-glucose-treated human retinal vascular endothelial cells (HRVECs), CPSF1 is downregulated; AAV-mediated CPSF1 restoration attenuates retinal histological abnormalities and regulates apoptosis, migration, and vascularization of HRVECs by suppressing MAPK/ERK phosphorylation. |
STZ-induced diabetic rat model, AAV-CPSF1 administration, high-glucose cell model, Western blotting for ERK phosphorylation, apoptosis/migration/tube formation assays |
Archives of physiology and biochemistry |
Medium |
32046510
|
| 2022 |
SIAH1 directly interacts with CPSF1 and promotes its ubiquitination and proteasomal degradation. CPSF1, regulated by this E3 ubiquitin ligase, promotes AR splice variant 7 (AR-v7) generation by binding to the AAUAAA polyadenylation signal in the AR cryptic exon CE3, switching the androgen receptor splicing pattern toward the oncogenic AR-v7 isoform. m6A methylation represses SIAH1, thereby stabilizing CPSF1 and promoting AR-v7 in castration-resistant prostate cancer. |
Microarray analysis, co-immunoprecipitation (SIAH1-CPSF1 interaction), ubiquitination assay, CPSF1 overexpression/knockdown, AR splicing assays, RIP (RNA immunoprecipitation) for CE3 binding, clinical specimen analysis |
Molecular therapy. Nucleic acids |
High |
35402071
|
| 2022 |
CPSF1 promotes gastric cancer progression by regulating alternative polyadenylation (APA) of NSDHL, shortening its 3'UTR; CPSF1 depletion reduces GC cell proliferation and metastasis. Rescue assays demonstrate that NSDHL mediates the oncogenic effect of CPSF1. |
RNA-seq for 3'UTR length changes, siRNA knockdown, overexpression, proliferation/invasion assays, rescue experiments with NSDHL re-expression |
American journal of cancer research |
Medium |
36381317
|
| 2023 |
CPSF1 functions as an E3 ubiquitin ligase that targets HIF-1α and MYC for proteasomal degradation. ABL kinases phosphorylate CUL4A and compete with CPSF1 for CUL4A binding, thereby protecting HIF-1α and MYC from CPSF1-mediated degradation under hypoxia. This was identified via a FACS-based CRISPR/Cas9 screen and validated biochemically. |
FACS-based CRISPR/Cas9 screen, co-immunoprecipitation, protein stability assays, kinase inhibitor treatment, proteasome inhibition, competitive binding assays between CPSF1 and ABL for CUL4A |
Proceedings of the National Academy of Sciences of the United States of America |
High |
37040401
|
| 2025 |
CPSF1 knockdown in prostate cancer cells causes widespread usage of intergenic poly(A) sites distal to annotated 3'UTRs, resulting in 3'UTR lengthening and decreased mRNA levels of thousands of genes including key glycolysis genes, and selectively inhibits growth and glycolytic output of prostate cancer cells. |
siRNA knockdown, global poly(A) site profiling (3'-end sequencing), RNA-seq, metabolic assays (glycolysis measurement), cell growth assays |
Cell reports |
High |
39847481
|
| 2025 |
HSF1 acts as a transcription factor that binds the promoter region of CPSF1 to regulate its transcription and expression. CPSF1 in turn modulates SREBP1 expression and participates in the AKT/mTOR signaling pathway to influence milk fat and protein synthesis in bovine mammary epithelial cells. |
Chromatin immunoprecipitation (ChIP) for HSF1 binding to CPSF1 promoter, siRNA knockdown, overexpression, Western blotting for AKT/mTOR/SREBP1 pathway components, milk fat/protein synthesis assays in MAC-T cells |
Journal of animal science |
Medium |
39932399
|